dezimal
DEZIMAL GmbH develops and sells RALV, a non-invasive optical device that lets ophthalmology clinics and refractive surgeons pre-test real intraocular lenses on patients before lens exchange surgery, using proprietary magnetic IOL shuttles and a companion app.
- Company typePrivate
- Founded2023
- HeadquartersVienna, Austria
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What dezimal does
DEZIMAL GmbH is a Vienna-based, privately held medical device company founded in 2023 that develops and sells RALV, a non-invasive optical system used by ophthalmology clinics and eye surgeons to predict patient-specific vision outcomes before refractive lens exchange surgery. RALV lets presbyopic patients look through real intraocular lenses (IOLs) mounted in proprietary magnetically inserted "IOL Shuttles," enabling rapid comparison of monofocal, EDoF, and multifocal (refractive and diffractive) lens designs at near, intermediate, and far distances. A companion RALV APP controls the device and runs quantitative tests (visual acuity, contrast sensitivity, halo/glare, full defocus curves) as well as a qualitative visual-impression test, supporting both objective IOL selection and patient counseling.
The underlying technology is a manufacturer-agnostic optical bench with a proprietary magnetic shuttle mechanism rather than an IOL- or vendor-tied system, allowing any standard IOL to be inserted into the optical path for evaluation. The system targets the workflow gap between preoperative biometry and postoperative outcomes — specifically the risk of patient dissatisfaction and surgical IOL explantation caused by incorrect lens selection.
DEZIMAL operates a direct, consultative enterprise sales motion to ophthalmology clinics, with quote-based (non-public) pricing and no disclosed channel partners, resellers, or recurring software subscription. The company maintains bilingual German/English web properties and a corporate LinkedIn page, signaling intent to address markets beyond its Austrian home base, but currently discloses no installed base, no named reference customers, no external funding rounds, no patents or regulatory clearances (e.g., CE mark / FDA), and no partnerships in the available source data. The company is led by Managing Directors Martin Kornfeld and Dr. Olivier La Schiazza and operates with 1–10 employees from its headquarters in Vienna's 10th district.
dezimal firmographics
Firmographics- Name
- dezimal
- Legal name
- DEZIMAL GmbH
- Website
- https://dezimal.me
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- DEZIMAL GmbH develops and sells RALV, a non-invasive optical device that lets ophthalmology clinics and refractive surgeons pre-test real intraocular lenses on patients before lens exchange surgery, using proprietary magnetic IOL shuttles and a companion app.
- Ownership category
- akta.pro rank
dezimal industry classification
Industry- Product category
- Ophthalmic Medical Devices
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance) (HLAHAJAG)
- akta.pro secondary industry
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)
Keywords
Where dezimal is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- Austria
- HQ region
- Europe
Offices1 record
Markets served
dezimal business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Revenue model
- RALV Device Sales: DEZIMAL generates revenue from the sale of the RALV optical system hardware to ophthalmology clinics and eye surgeons. The system includes the device, IOL shuttles, and associated software/app. The company is compatible with all IOL manufacturers, suggesting a hardware-first business model.
- IOL Shuttle Consumables/Accessories: IOL shuttles are required for mounting different intraocular lenses in the RALV system, which may generate recurring revenue through replacement or expansion purchases as clinics work with different IOL types.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
dezimal product offering
Product offeringCore offering
DEZIMAL sells the RALV® optical system, a non-invasive medical device that allows presbyopic patients to look through real intraocular lenses (IOLs) via proprietary magnetic IOL Shuttles before refractive lens exchange surgery. The system includes the RALV hardware, the IOL Shuttles, and the RALV APP, which together support subjective IOL comparison and quantitative measurement of visual acuity, contrast sensitivity, halo/glare, and defocus curves to enable optimal patient-specific IOL selection.
Product overview
DEZIMAL offers a single unified product called RALV®, a non-invasive optical system designed for ophthalmologists and eye clinics. The system consists of the RALV hardware device, proprietary IOL Shuttles for mounting and comparing different intraocular lenses, and the RALV APP for device control and vision testing. RALV enables pre-operative simulation and measurement of visual acuity, contrast sensitivity, halo/glare, and defocus curves to help patients select the most suitable IOL before refractive lens exchange surgery.
Differentiator
Problem solved
Functional benefit
Brands
- RALV®: Non-invasive optical system for precise prediction of achievable vision after refractive lens exchange. Enables presbyopic patients to experience postoperative vision before implantation by testing real intraocular lenses on objects and vision charts.
Products and services
- RALV® Optical System A non-invasive optical device sold to ophthalmology clinics and eye surgeons that allows presbyopic patients to look through real intraocular lenses (IOLs) before refractive lens exchange surgery. It consists of the RALV hardware, proprietary magnetic IOL Shuttles for mounting and rapidly exchanging IOLs, and the RALV APP for device control and conducting visual acuity, contrast sensitivity, halo/glare, and defocus curve tests. The system is manufacturer-agnostic and compatible with all standard IOL types, supporting both subjective patient evaluation and quantitative vision measurement to optimize IOL selection.
Quantifiable outcome
- Highest possible patient satisfaction after refractive lens exchange
- +2 more outcomes
Companies that use dezimal
Customer profileSegments1 record
Ideal customer profiles1 record
dezimal technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
dezimal partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
dezimal competitors and assessment
Company assessmentDirect peers
- 2EyesVision: Spanish developer of the SimVis binocular simulator, which lets patients experience vision through different IOLs pre-surgery. Closest direct functional analog to RALV in the pre-surgical IOL simulation niche.
Broad incumbents
- Carl Zeiss Meditec: Large ophthalmic device maker whose IOLMaster biometry and cataract/refractive suites are widely deployed in clinics performing RLE. Competes for the pre-surgical planning workflow that RALV targets.
- Alcon: Global leader in IOLs (PanOptix, Vivity) and cataract/refractive surgical equipment. Could bundle or build a competing IOL simulation capability into its surgical planning ecosystem.
- Johnson & Johnson Vision: Sells the TECNIS IOL family and related cataract/refractive planning tools. Comparable as a vertically integrated competitor that could integrate pre-surgical simulation into its IOL portfolio.
- Bausch + Lomb: Major IOL and cataract-surgery equipment manufacturer with a broad ophthalmic portfolio. Adjacent incumbent in the same surgeon-and-clinic purchasing motion DEZIMAL targets.
Emerging players
- Heidelberg Engineering: Specialist in ophthalmic diagnostic imaging (OCT, perimetry) used in pre-surgical assessment workflows. Comparable as a niche device vendor selling premium ophthalmic diagnostic hardware to the same clinic customers.
- Oculus Optikgeräte: German maker of ophthalmic diagnostic devices including wavefront aberrometers and IOL-related measurement systems. Comparable as a mid-sized European specialist selling pre-operative ophthalmic measurement hardware.
- Ziemer Ophthalmic Systems: Swiss-based developer of ophthalmic surgical lasers and diagnostics for cataract/refractive surgery. Comparable as a small-to-mid European specialist selling surgical workflow hardware into the same clinics.
Regional players
- Nidek: Japanese ophthalmic equipment maker producing surgical and diagnostic devices for cataract and refractive surgeons. Comparable product category but primarily distributed outside DACH.
- Topcon Healthcare: Japanese ophthalmic diagnostic and surgical equipment vendor with strong presence in pre-operative biometry and imaging. Comparable device category with limited direct overlap in DACH.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
dezimal social profiles
Digital presencedezimal financial estimates
Financial estimateRevenue estimate
Valuation estimate
dezimal leadership team
Management profileNumber of profiles
Profiles2 records
dezimal funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
dezimal M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about dezimal
What does dezimal do?
DEZIMAL sells the RALV® optical system, a non-invasive medical device that allows presbyopic patients to look through real intraocular lenses (IOLs) via proprietary magnetic IOL Shuttles before refractive lens exchange surgery. The system includes the RALV hardware, the IOL Shuttles, and the RALV APP, which together support subjective IOL comparison and quantitative measurement of visual acuity, contrast sensitivity, halo/glare, and defocus curves to enable optimal patient-specific IOL selection.
Is dezimal a public or private company?
dezimal is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was dezimal founded?
dezimal was founded in 2023. It employs 1 to 10 people.
Where is dezimal based?
dezimal is headquartered in Vienna, Austria, in the Europe region.
How does dezimal make money?
Two revenue lines are on record. RALV Device Sales are the primary driver. The others are IOL Shuttle Consumables/Accessories.
Who are dezimal's main competitors?
2EyesVision is listed as a direct peer. Broad incumbents are Carl Zeiss Meditec, Alcon, Johnson & Johnson Vision and Bausch + Lomb. Emerging players are Heidelberg Engineering, Oculus Optikgeräte and Ziemer Ophthalmic Systems. Regional players are Nidek and Topcon Healthcare.
Does dezimal have an API?
No public API is recorded for dezimal.
What industry is dezimal in?
dezimal's product category is Ophthalmic Medical Devices. Its primary akta.pro industry code is HLAHAJAG, Refractive Surgery Systems (Excimer/Femtosecond Lasers, Phakic IOL Systems, Wavefront/Guidance), with a secondary code of HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 339115 and its SIC code is 3841.